Is Panlong Pharmaceutical a leading pharmaceutical stock?

According to Aiqi's investigation data, Shaanxi Panlong Pharmaceutical Group Co., Ltd. (referred to as Panlong Pharmaceutical; Stock code: 002864) was established in 1997. It is a modern high-tech enterprise with GAP cultivation, pharmaceutical production, research and development, sales and pharmaceutical logistics as its core industries. The company has established more than 130 specialized offices, and the product marketing network covers the whole country, which is deeply trusted and praised by doctors, experts and patients. The company has been rated as "National Leading Enterprise for Poverty Alleviation" by the National Poverty Alleviation Office, "National Contract-abiding and Credit-abiding Unit" by the State Administration for Industry and Commerce, and "Shaanxi Provincial Advanced Collective", "May 1 Labor Award", "Excellent Private Enterprise", "Contract-abiding and Credit-abiding Enterprise" and "Outstanding Contribution Award for the Development of the Western Region" by the Shaanxi Provincial Party Committee and Government. It has been rated as "Honest Enterprise in Shaanxi Province", "Advanced Unit in Quality Work in Shaanxi Province", "Leading Enterprise in Agricultural Industrialization in Shaanxi Province", "Innovative Enterprise in Shaanxi Province", "High-tech Enterprise", "Science and Technology Demonstration Enterprise" and "Model Taxpayer" by the relevant departments of the province, and won more than one award 100, and was commended and rewarded many times.